Induction of Functional IL-8 Receptors by IL-4 and IL-13 in Human Monocytes1
暂无分享,去创建一个
P. Allavena | A. Mantovani | S. Sozzani | W. Luini | F. Facchetti | R. Bonecchi | M. Locati | F. Rossi | E. Brandt | S. Dusi | S. Bernasconi | D. Lissandrini | M. Simmelink | A. Mantovani
[1] A. Mantovani,et al. The chemokine system: redundancy for robust outputs. , 1999, Immunology today.
[2] F. Rossi,et al. β-Amyloid Activates the O⨪2 Forming NADPH Oxidase in Microglia, Monocytes, and Neutrophils , 1999, The Journal of Biological Chemistry.
[3] F. Rossi,et al. beta-amyloid activates the O-2 forming NADPH oxidase in microglia, monocytes, and neutrophils. A possible inflammatory mechanism of neuronal damage in Alzheimer's disease. , 1999, The Journal of biological chemistry.
[4] F. Luscinskas,et al. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions , 1999, Nature.
[5] S. Goerdt,et al. Other functions, other genes: alternative activation of antigen-presenting cells. , 1999, Immunity.
[6] A. Lentsch,et al. Regulation of acute lung inflammatory injury by endogenous IL-13. , 1999, Journal of immunology.
[7] M Locati,et al. Chemokines and chemokine receptors: biology and clinical relevance in inflammation and AIDS. , 1999, Annual review of medicine.
[8] C. Mackay,et al. Up-regulation of CCR1 and CCR3 and induction of chemotaxis to CC chemokines by IFN-gamma in human neutrophils. , 1999, Journal of immunology.
[9] R. Badolato,et al. Expression of inducible nitric oxide synthase in human granulomas and histiocytic reactions. , 1999, The American journal of pathology.
[10] M. Rihanek,et al. STCP-1 (MDC) CC chemokine acts specifically on chronically activated Th2 lymphocytes and is produced by monocytes on stimulation with Th2 cytokines IL-4 and IL-13. , 1998, Journal of immunology.
[11] P. Allavena,et al. Divergent effects of interleukin-4 and interferon-gamma on macrophage-derived chemokine production: an amplification circuit of polarized T helper 2 responses. , 1998, Blood.
[12] D. Kelvin,et al. CXCR1 and CXCR2 are rapidly down-modulated by bacterial endotoxin through a unique agonist-independent, tyrosine kinase-dependent mechanism. , 1998, Journal of immunology.
[13] C. Bruijnzeel-Koomen,et al. A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. , 1998, Immunology today.
[14] O. Yoshie,et al. Identification of Single C Motif-1/Lymphotactin Receptor XCR1* , 1998, The Journal of Biological Chemistry.
[15] D. Dichek,et al. Adhesion of monocytes to vascular cell adhesion molecule-1-transduced human endothelial cells: implications for atherogenesis. , 1998, Circulation research.
[16] J. Bousquet,et al. Cutting Edge: IL-4 Induces Functional Cell-Surface Expression of CXCR4 on Human T Cells , 1998, The Journal of Immunology.
[17] A. Sica,et al. Selective inhibition of expression of the chemokine receptor CCR2 in human monocytes by IFN-gamma. , 1998, Journal of immunology.
[18] D. Weissman,et al. Dendritic cells express multiple chemokine receptors used as coreceptors for HIV entry. , 1998, Journal of immunology.
[19] M. Baggiolini. Chemokines and leukocyte traffic , 1998, Nature.
[20] C. Mackay,et al. Interleukin 10 Increases CCR5 Expression and HIV Infection in Human Monocytes , 1998, The Journal of experimental medicine.
[21] S. Goerdt,et al. Alternative macrophage activation-associated CC-chemokine-1, a novel structural homologue of macrophage inflammatory protein-1 alpha with a Th2-associated expression pattern. , 1998, Journal of immunology.
[22] R. Terkeltaub,et al. A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice. , 1998, The Journal of clinical investigation.
[23] P. Proost,et al. Interleukin-8 and other CXC chemokines , 1998 .
[24] P. Allavena,et al. Chemokines and chemokine receptors during activation and deactivation of monocytes and dendritic cells and in amplification of Th1 versus Th2 responses , 1998, International journal of clinical & laboratory research.
[25] J. Bousquet,et al. IL-4 induces functional cell-surface expression of CXCR4 on human T cells. , 1998, Journal of immunology.
[26] T. Mayadas,et al. A Role for Mac-1 (CDIIb/CD18) in Immune Complex–stimulated Neutrophil Function In Vivo: Mac-1 Deficiency Abrogates Sustained Fcγ Receptor–dependent Neutrophil Adhesion and Complement-dependent Proteinuria in Acute Glomerulonephritis , 1997, The Journal of experimental medicine.
[27] O. Götze,et al. The CXC-chemokine neutrophil-activating peptide-2 induces two distinct optima of neutrophil chemotaxis by differential interaction with interleukin-8 receptors CXCR-1 and CXCR-2. , 1997, Blood.
[28] P. Allavena,et al. Human monocyte‐derived and CD34+ cell‐derived dendritic cells express functional receptors for platelet activating factor , 1997, FEBS letters.
[29] D. Kelvin,et al. Regulation of CCR2 chemokine receptor mRNA stability , 1997, Journal of leukocyte biology.
[30] M. Gobbi,et al. Receptor expression and responsiveness of human dendritic cells to a defined set of CC and CXC chemokines. , 1997, Journal of immunology.
[31] T. Mcclanahan,et al. A dendritic-cell-derived C–C chemokine that preferentially attracts naive T cells , 1997, Nature.
[32] S. Romagnani,et al. The Th1/Th2 paradigm. , 1997, Immunology today.
[33] A. Mantovani,et al. Cytokine regulation of endothelial cell function: from molecular level to the bedside. , 1997, Immunology today.
[34] O. Götze,et al. Chemoattractant receptors for interleukin‐8 and C5a: expression on peripheral blood leukocytes and differential regulation on HL‐60 and AML‐193 cells by vitamin D3 and all‐trans rètinoic acid , 1997, European journal of immunology.
[35] K. Murao,et al. Regulation of Expression of the Human Monocyte Chemotactic Protein-1 Receptor (hCCR2) by Cytokines* , 1997, The Journal of Biological Chemistry.
[36] A. Sica,et al. Bacterial Lipopolysaccharide Rapidly Inhibits Expression of C–C Chemokine Receptors in Human Monocytes , 1997, The Journal of experimental medicine.
[37] B Dewald,et al. Human chemokines: an update. , 1997, Annual review of immunology.
[38] F. DeLeo,et al. Assembly of the phagocyte NADPH oxidase: molecular interaction of oxidase proteins , 1996, Journal of leukocyte biology.
[39] A. Tall,et al. Interleukin 8 Is Induced by Cholesterol Loading of Macrophages and Expressed by Macrophage Foam Cells in Human Atheroma (*) , 1996, The Journal of Biological Chemistry.
[40] C. Mackay,et al. Expression of monocyte chemoattractant protein‐1 and interleukin‐8 receptors on subsets of T cells: correlation with transendothelial chemotactic potential , 1996, European journal of immunology.
[41] L. Notarangelo,et al. CD30 cell expression and abnormal soluble CD30 serum accumulation in Omenn's syndrome: Evidence for a T helper 2‐mediated condition , 1996, European journal of immunology.
[42] H. Mizoguchi,et al. Activation and priming of human monocytes by monocyte chemotactic activating factor: cooperation with other inflammatory cytokines and close association between an increase in cytoplasmic free Ca2+ and intracellular acidification. , 1996, Experimental hematology.
[43] A. Manning,et al. TGF-β1, IL-10 and IL-4 differentially modulate the cytokine-induced expression of IL-6 and IL-8 in human endothelial cells , 1996 .
[44] K. Nilsson,et al. Monocytes and Macrophages , 1996 .
[45] F. Luscinskas,et al. Endothelial-dependent mechanisms in chronic inflammatory leukocyte recruitment. , 1996, Annual review of medicine.
[46] D. Taub,et al. Granulocyte-Colony Stimulating Factor and Lipopolysaccharide Regulate the Expression of Interleukin 8 Receptors on Polymorphonuclear Leukocytes (*) , 1995, The Journal of Biological Chemistry.
[47] P. Ferrara,et al. Experimental gene therapy of cancer using tumor cells engineered to secrete interleukin‐13 , 1995, European journal of immunology.
[48] Konrad M. Hartung,et al. IL-8 is expressed by human peripheral blood eosinophils. Evidence for increased secretion in asthma. , 1995, Journal of immunology.
[49] K. Fearon,et al. Interleukin-4 and interleukin-10 increase endotoxin-stimulated human umbilical vein endothelial cell interleukin-8 release. , 1995, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[50] S. Murakami,et al. Expression of both types of human interleukin‐8 receptors on mature neutrophils, monocytes, and natural killer cells , 1995, Journal of leukocyte biology.
[51] A. Chuntharapai,et al. Monoclonal antibodies detect different distribution patterns of IL-8 receptor A and IL-8 receptor B on human peripheral blood leukocytes. , 1994, Journal of immunology.
[52] A. Mantovani,et al. Activation of phospholipase D by interleukin-8 in human neutrophils. , 1994, Blood.
[53] S. Bernasconi,et al. Regulation of endothelial and mesothelial cell function by interleukin-13: selective induction of vascular cell adhesion molecule-1 and amplification of interleukin-6 production. , 1994, Blood.
[54] P. Ferrara,et al. Interleukin-13 is a monocyte chemoattractant. , 1994, European cytokine network.
[55] G S Kansas,et al. Monocyte rolling, arrest and spreading on IL-4-activated vascular endothelium under flow is mediated via sequential action of L-selectin, beta 1-integrins, and beta 2-integrins , 1994, The Journal of cell biology.
[56] S. Gordon,et al. Interleukin‐13 alters the activation state of murine macrophages in vitro: Comparison with interleukin‐4 and interferon‐γ , 1994, European journal of immunology.
[57] A. Mantovani,et al. Interleukin-13 induces the production of interleukin-1 receptor antagonist (IL-1ra) and the expression of the mRNA for the intracellular (keratinocyte) form of IL-1ra in human myelomonocytic cells. , 1994, Blood.
[58] T. Springer. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm , 1994, Cell.
[59] A. Thomson. The cytokine handbook , 1994 .
[60] M. Baggiolini,et al. Expression of transcripts for two interleukin 8 receptors in human phagocytes, lymphocytes and melanoma cells. , 1993, The Biochemical journal.
[61] T. Standiford,et al. Gene expression of macrophage inflammatory protein-1 alpha from human blood monocytes and alveolar macrophages is inhibited by interleukin-4. , 1993, American journal of respiratory cell and molecular biology.
[62] A. Mantovani,et al. Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. , 1993, Science.
[63] S Gordon,et al. Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation , 1992, The Journal of experimental medicine.
[64] J. Schröder,et al. Neutrophil-activating proteins in psoriasis. , 1992, The Journal of investigative dermatology.
[65] L. Mcphail,et al. The neutrophil respiratory burst mechanism. , 1992, Immunology series.
[66] R. Coffey. Granulocyte responses to cytokines. Basic and clinical research. , 1992, Immunology series.
[67] A. Mantovani,et al. The signal transduction pathway involved in the migration induced by a monocyte chemotactic cytokine. , 1991, Journal of immunology.
[68] M. Baggiolini,et al. [Ca2+]i Changes and Respiratory Burst in Human Neutrophils and Monocytes Induced by NAP‐1/Interleukin‐8, NAP‐2, and gro/MGSA , 1991, Journal of leukocyte biology.
[69] C. Nathan,et al. Gram‐negative endotoxin: an extraordinary lipid with profound effects on eukaryotic signal transduction 1 , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[70] S. Becker,et al. Antagonistic and additive effects of IL-4 and interferon-gamma on human monocytes and macrophages: effects on Fc receptors, HLA-D antigens, and superoxide production. , 1990, Cellular immunology.
[71] E. Appella,et al. Properties of monocyte chemotactic and activating factor (MCAF) purified from a human fibrosarcoma cell line , 1990, The Journal of experimental medicine.
[72] J. Van Damme,et al. Granulocyte chemotactic protein/interleukin-8 induces plasma leakage and neutrophil accumulation in rabbit skin. , 1989, The American journal of pathology.
[73] P. Hart,et al. Potential antiinflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor alpha, interleukin 1, and prostaglandin E2. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[74] B. Dewald,et al. In vivo inflammatory activity of neutrophil-activating factor, a novel chemotactic peptide derived from human monocytes. , 1989, The American journal of pathology.
[75] M. Baggiolini,et al. Mechanism of neutrophil activation by NAF, a novel monocyte‐derived peptide agonist , 1988, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[76] B. Babior. The respiratory burst oxidase. , 1988, Hematology/oncology clinics of North America.
[77] B. Dewald,et al. A novel neutrophil-activating factor produced by human mononuclear phagocytes , 1988, The Journal of experimental medicine.
[78] J. van Beeumen,et al. A novel, NH2-terminal sequence-characterized human monokine possessing neutrophil chemotactic, skin-reactive, and granulocytosis-promoting activity , 1988, The Journal of experimental medicine.
[79] R. Johnston. Current concepts: immunology. Monocytes and macrophages. , 1988, The New England journal of medicine.
[80] C. Nathan,et al. Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity , 1983, The Journal of experimental medicine.
[81] C. Werning. [Rheumatoid arthritis]. , 1983, Medizinische Monatsschrift fur Pharmazeuten.